par Pritchard, Kathleen;Burris, Howard H.A.;Ito, Yoshinori;Rugo, Hope;Dakhil, Shaker;Hortobagyi, Gabriel N.;Campone, Mario;Csöszi, Tibor;Baselga, José;Puttawibul, Puttisak;Piccart-Gebhart, Martine
;Heng, Daniel Y C;Noguchi, Shinzaburo;Srimuninnimit, Vichien;Bourgeois, Hugues;Gonzalez Martin, Antonio;Osborne, Karen;Panneerselvam, Ashok;Taran, Tetiana;Sahmoud, Tarek;Gnant, Michael
Référence Clinical breast cancer, 13, 6, page (421-432)
Publication Publié, 2013
;Heng, Daniel Y C;Noguchi, Shinzaburo;Srimuninnimit, Vichien;Bourgeois, Hugues;Gonzalez Martin, Antonio;Osborne, Karen;Panneerselvam, Ashok;Taran, Tetiana;Sahmoud, Tarek;Gnant, MichaelRéférence Clinical breast cancer, 13, 6, page (421-432)
Publication Publié, 2013
Article révisé par les pairs
| Titre: |
|
| Auteur: | Pritchard, Kathleen; Burris, Howard H.A.; Ito, Yoshinori; Rugo, Hope; Dakhil, Shaker; Hortobagyi, Gabriel N.; Campone, Mario; Csöszi, Tibor; Baselga, José; Puttawibul, Puttisak; Piccart-Gebhart, Martine; Heng, Daniel Y C; Noguchi, Shinzaburo; Srimuninnimit, Vichien; Bourgeois, Hugues; Gonzalez Martin, Antonio; Osborne, Karen; Panneerselvam, Ashok; Taran, Tetiana; Sahmoud, Tarek; Gnant, Michael |
| Informations sur la publication: | Clinical breast cancer, 13, 6, page (421-432) |
| Statut de publication: | Publié, 2013 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Advanced breast cancer |
| Endocrine resistance | |
| Geriatric | |
| Progression-free survival | |
| Safety | |
| MeSH keywords: | Aged |
| Aged, 80 and over | |
| Androstadienes -- administration & dosage | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| International Agencies | |
| Neoplasm Metastasis | |
| Neoplasm Recurrence, Local -- drug therapy -- pathology | |
| Neoplasm Staging | |
| Prognosis | |
| Receptor, ErbB-2 -- metabolism | |
| Receptors, Estrogen -- metabolism | |
| Receptors, Progesterone -- metabolism | |
| Safety | |
| Sirolimus -- administration & dosage -- analogs & derivatives | |
| Survival Rate | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1526-8209 |
| info:doi/10.1016/j.clbc.2013.08.011 | |
| info:pii/S1526820913001857 | |
| info:scp/84889008307 | |
| info:pmid/24267730 |



